サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1477100

薬剤溶出コーティング市場：タイプ別、用途別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測

Drug-Eluting Coating Market, By Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 289 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
薬剤溶出コーティング市場：タイプ別、用途別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年04月25日
発行: AnalystView Market Insights
ページ情報: 英文 289 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

薬剤溶出コーティング市場規模は2023年に27億8,934万米ドルとなり、2024年から2032年にかけてCAGR 8.7%で拡大

薬剤溶出コーティング市場- 市場力学

低侵襲手術への需要の高まりが市場成長を牽引

薬剤溶出ステントと小切開を採用することで冠動脈の狭窄や閉塞を修復する低侵襲手術の需要が増加していることから、市場の拡大が見込まれます。例えば2023年1月、米国国立医学図書館は、米国で毎年行われている低侵襲手術の症例数が300万件を超えたという論文を発表しました。これらの手術には、身体的外傷が少ない、回復が早い、入院期間が短い、トラブルが少ないなど、いくつかの利点があります。その結果、低侵襲手術の需要の増加により、薬剤溶出ステントの市場開拓が期待されています。

薬剤溶出コーティング市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024～2032年）に約8.7%のCAGRで毎年成長すると推定されています。

タイプ別では、ドラッグデリバリーコーティングが予測期間中に最大の収益シェアを獲得する見込みです。

用途別では、病院分野が予測期間中に市場を独占すると予測されます。

地域別では、北米が予測期間で市場を独占すると予測されます。

薬剤溶出コーティング市場-セグメンテーション分析：

薬剤溶出コーティングの世界市場は、タイプ、用途、地域に基づいてセグメント化されます。

タイプ別では、薬物送達コーティング、生体適合性コーティング、ポリマーフリーコーティング/サーフェスに二分されます。ドラッグデリバリーコーティングセグメントは、予測期間中に最大の収益シェアを獲得する見込みです。このセグメントの増加は、慢性疾患の有病率の上昇に起因しています。糖尿病、がん、心血管障害などの慢性疾患の世界の負担が増加するにつれて、薬剤溶出コーティングを施した革新的な医療機器の人気が高まっています。これらの医療機器は、患者のQOLと治療成績の向上を目指しています。

薬剤溶出コーティングの世界市場は、用途に基づき、研究所と病院に区分されます。予測期間中、病院セグメントが市場を独占すると予想されます。低侵襲手術に対する需要の高まりが、このセグメントの成長を牽引しています。

薬剤溶出コーティング市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。予測期間中、北米が市場を独占すると見られています。確立されたヘルスケアインフラの存在や薬剤溶出ステントの技術開拓も市場拡大の原動力となっています。例えば、2023年2月に発表されたJournal of the American College of Cardiologyによると、米国におけるアテローム性動脈硬化性心血管病の罹患率は、10年予測リスクが上昇した人では1,000人年当たり2.60人、10年予測リスクは低いが30年予測リスクが上昇した人では1.87人、10年予測リスクと30年予測リスクが低い人では0.32人でした。その結果、アテローム性動脈硬化性心血管疾患の有病率の増加が薬剤溶出ステント治療の必要性を高め、地域市場の拡大を後押ししています。

薬剤溶出コーティング市場-競合情勢：

市場で事業を展開する主要企業は、Covalon Technologies Ltd.、Carmeda AB、AST Products, Inc.、Biophan Technologies, Inc.、Biocoat, Inc.、Hemoteq AG、Armoloy of Connecticut, Inc.、Nanocopoeia, Inc.、Hydromer, Inc.、N2 Biomedicalです。これらの企業は、製品発売、買収、提携など、この業界で大きなシェアを獲得するために様々な戦略を採用しています。

目次

第1章 薬剤溶出コーティング市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 薬剤溶出コーティングの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 薬剤溶出コーティング産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 薬剤溶出コーティング市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 薬剤溶出コーティング市場情勢

  • 薬剤溶出コーティング市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 薬剤溶出コーティング市場- タイプ別

  • 概要
    • タイプ別セグメントシェア分析
    • 薬物送達コーティング
    • 生体適合性コーティング
    • ポリマーフリーコーティング/サーフェス

第8章 薬剤溶出コーティング市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 調査機関
    • 病院

第9章 薬剤溶出コーティング市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- 薬剤溶出コーティング業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Covalon Technologies Ltd.
    • Carmeda AB
    • AST Products, Inc.
    • Biophan Technologies, Inc.
    • Biocoat, Inc.
    • Hemoteq AG
    • Armoloy of Connecticut, Inc.
    • Nanocopoeia, Inc.
    • Hydromer, Inc.
    • N2 Biomedical

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Drug-Eluting Coating Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Drug-Eluting Coating Market, by Type 2019-2032 (USD Million)
  • TABLE Drug-Eluting Coating Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Drug-Eluting Coating Market, by Application 2019-2032 (USD Million)
  • TABLE Drug-Eluting Coating Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Drug-Eluting Coating Market, by Region 2019-2032 (USD Million)
  • TABLE North America Drug-Eluting Coating Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Drug-Eluting Coating Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Drug-Eluting Coating Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Drug-Eluting Coating Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Drug-Eluting Coating Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Drug-Eluting Coating Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Drug-Eluting Coating Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Drug-Eluting Coating Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Drug-Eluting Coating Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Drug-Eluting Coating Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Drug-Eluting Coating Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Drug-Eluting Coating Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Drug-Eluting Coating Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Drug-Eluting Coating Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Drug-Eluting Coating Market, by Application, 2019-2032 (USD Million)
目次
Product Code: ANV2496

REPORT HIGHLIGHT

Drug-Eluting Coating Market size was valued at USD 2,789.34 Million in 2023, expanding at a CAGR of 8.7% from 2024 to 2032.

When a particular layer is placed on medical equipment, such as implants or stents, it's called a drug-eluting coating. Its purpose is to release medication gradually. These coatings can promote healing, lessen inflammation, stop infection, or stop the growth of scar tissue, among other functions. These coatings can lower the risk of problems and increase the efficacy of the device by releasing medications gradually at the site of implantation. The medications used and the coating's formulation is based on the particular medical application and the intended therapeutic results.

Drug-Eluting Coating Market- Market Dynamics

Increasing demand for minimally invasive surgeries drives market growth

The market is anticipated to rise due to the increasing demand for minimally invasive operations, which repair restricted or blocked coronary arteries by employing drug-eluting stents and small incisions. In January 2023, for instance, the National Library of Medicine issued an article stating that the number of cases of minimally invasive surgery performed in the US each year exceeded three million. These operations have several benefits, including less physical trauma, quicker recovery periods, shorter hospital stays, and fewer problems. As a result, the market for drug-eluting stents is expected to develop due to the increased demand for minimally invasive procedures.

Drug-Eluting Coating Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.7% over the forecast period (2024-2032)

Based on type segmentation, the Drug-delivery Coatings segment is expected to capture the largest revenue share over the projected period

Based on application segmentation, the hospital segment is expected to dominate the market over the projected period

Based on region, North America is expected to dominate the market over the forecast period

Drug-Eluting Coating Market- Segmentation Analysis:

The Global Drug-Eluting Coating Market is segmented based on Type, Application and Region.

Based on the type, the Drug-Eluting Coating market is bifurcated into Drug-delivery Coatings, Biocompatible Coatings and Polymer-free Coatings/Surfaces. The Drug-delivery Coatings segment is expected to capture the largest revenue share over the projected period. The segment increase is owing to the rising prevalence of chronic disease. Innovative medical devices with drug-eluting coatings are in increasing popularity as the worldwide burden of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, rises. These devices aim to improve patient quality of life and treatment outcomes.

Based on the application, the global Drug-Eluting Coating market is segmented into Research Institute and Hospital. The Hospital segment is expected to dominate the market over the projected period. The growing demand for minimally invasive surgery driving the segment growth.

Drug-Eluting Coating Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The existence of well-established healthcare infrastructure and technological developments in drug-eluting stents are also driving the market's expansion. For example, the incidence rate of atherosclerotic cardiovascular disease was 2.60 per 1,000 person-years among those with a raised 10-year predicted risk, 1.87 in those with a low 10-year but elevated 30-year predicted risk, and 0.32 in those with low 10-year and 30-year predicted risk in the United States, according to the Journal of the American College of Cardiology published in February 2023. As a result, the increased prevalence of atherosclerotic cardiovascular disease raises the need for drug-eluting stent therapy, which propels regional market expansion.

Drug-Eluting Coating Market- Competitive Landscape:

The key players operating in the market are Covalon Technologies Ltd., Carmeda AB, AST Products, Inc., Biophan Technologies, Inc., Biocoat, Inc., Hemoteq AG, Armoloy of Connecticut, Inc., Nanocopoeia, Inc., Hydromer, Inc. and N2 Biomedical. These players adopted various strategies to gain major market share in the industry including product launches, acquisitions, collaboration and others.

Recent Development:

In June 2023, The FDA in the United States approved the SurVeilTM drug-coated balloon (DCB). Surmodics, Inc. is a prominent supplier of medical devices and in vitro diagnostic technologies to the healthcare sector.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL Drug-Eluting Coating MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Covalon Technologies Ltd.

Carmeda AB

AST Products, Inc.

Biophan Technologies, Inc.

Biocoat, Inc.

Hemoteq AG

Armoloy of Connecticut, Inc.

Nanocopoeia, Inc.

Hydromer, Inc.

N2 Biomedical

GLOBAL Drug-Eluting Coating MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Drug-delivery Coatings
  • Biocompatible Coatings
  • Polymer-free Coatings/Surfaces

GLOBAL Drug-Eluting Coating MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Research Institute
  • Hospital

GLOBAL Drug-Eluting Coating MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Drug-Eluting Coating Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Drug-Eluting Coating Market Snippet by Type
    • 2.1.2.Drug-Eluting Coating Market Snippet by Application
    • 2.1.3.Drug-Eluting Coating Market Snippet by Country
    • 2.1.4.Drug-Eluting Coating Market Snippet by Region
  • 2.2.Competitive Insights

3.Drug-Eluting Coating Key Market Trends

  • 3.1.Drug-Eluting Coating Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Drug-Eluting Coating Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Drug-Eluting Coating Market Opportunities
  • 3.4.Drug-Eluting Coating Market Future Trends

4.Drug-Eluting Coating Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Drug-Eluting Coating Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Drug-Eluting Coating Market Landscape

  • 6.1.Drug-Eluting Coating Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Drug-Eluting Coating Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Drug-delivery Coatings
    • 7.1.3.Biocompatible Coatings
    • 7.1.4.Polymer-free Coatings/Surfaces

8.Drug-Eluting Coating Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Research Institute
    • 8.1.3.Hospital

9.Drug-Eluting Coating Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Drug-Eluting Coating Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Drug-Eluting Coating Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Drug-Eluting Coating Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Drug-Eluting Coating Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Drug-Eluting Coating Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Drug-Eluting Coating Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Covalon Technologies Ltd.
    • 10.2.2.Carmeda AB
    • 10.2.3.AST Products, Inc.
    • 10.2.4.Biophan Technologies, Inc.
    • 10.2.5.Biocoat, Inc.
    • 10.2.6.Hemoteq AG
    • 10.2.7.Armoloy of Connecticut, Inc.
    • 10.2.8.Nanocopoeia, Inc.
    • 10.2.9.Hydromer, Inc.
    • 10.2.10.N2 Biomedical

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us